The Sphingosine Kinase 1 Inhibitor, PF543, Mitigates Pulmonary Fibrosis by Reducing Lung Epithelial Cell mtDNA Damage and Recruitment of Fibrogenic Monocytes

Idiopathic pulmonary fibrosis (IPF) is a chronic disease for which novel approaches are urgently required. We reported increased sphingosine kinase 1 (SPHK1) in IPF lungs and that SPHK1 inhibition using genetic and pharmacologic approaches reduces murine bleomycin-induced pulmonary fibrosis. We dete...

全面介紹

Na minha lista:
書目詳細資料
發表在:Int J Mol Sci
Main Authors: Cheresh, Paul, Kim, Seok-Jo, Huang, Long Shuang, Watanabe, Satoshi, Joshi, Nikita, Williams, Kinola J.N., Chi, Monica, Lu, Ziyan, Harijith, Anantha, Yeldandi, Anjana, Lam, Anna P., Gottardi, Cara, Misharin, Alexander V., Budinger, G.R. Scott, Natarajan, Viswanathan, Kamp, David W.
格式: Artigo
語言:Inglês
出版: MDPI 2020
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7460639/
https://ncbi.nlm.nih.gov/pubmed/32764262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21165595
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍